Cresset Asset Management, LLC Charles River Laboratories International, Inc. Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 5,627 shares of CRL stock, worth $875,279. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,627
Previous 6,754
16.69%
Holding current value
$875,279
Previous $1.33 Million
21.95%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$958 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$791 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$339 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$281 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$281 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.91B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...